Showing results (181-190 of 195) with videos related to
Sort By:
Pageof 20
British Journal of Cancer|February 1, 2014
Focal amplification of the androgen receptor gene in hormone-naive human prostate cancerS Merson, Z H Yang, D Brewer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association StudyW Jonat, M Kaufmann, W Sauerbrei, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2015
Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtypeM Gnant, I Sestak, M Filipits, et al.Oncogene|July 20, 2007
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancerG Attard, J Clark, L Ambroisine, et al.Journal of Internal Medicine|February 2, 2012
Prevention of breast cancer in the context of a national breast screening programmeA Howell, S Astley, J Warwick, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2014
Estimates of benefits and harms of prophylactic use of aspirin in the general populationJ Cuzick, M A Thorat, C Bosetti, et al.International Journal of Obesity (2005)|October 6, 2010
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight womenM N Harvie, M Pegington, M P Mattson, et al.British Journal of Cancer|July 3, 2008
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancerG Attard, J Clark, L Ambroisine, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2016
Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trialN Zdenkowski, J F Forbes, F M Boyle, et al.American Journal of Human Genetics|April 16, 2003
An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndromeE E M Jaeger, K L Woodford-Richens, M Lockett, et al.Pageof 20